Contingent negative variation as a dopaminergic biomarker: Evidence from dose-related effects of methylphenidate

Psychopharmacology

Volumn 218, Issue 3, 2011, Pages 533-542

  Linssen, Anke M W ^a   Vuurman, Eric F P M ^a   Sambeth, Anke ^a   Nave, Stephane ^b   Spooren, Will ^b   Vargas, Gabriel ^b   Santarelli, Luca ^b   Riedel, Wim J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Contingent negative variation; Dopamine; Event related potentials; Methylphenidate; Response preparation

Indexed keywords

DOPAMINE; HYDROCORTISONE; METHYLPHENIDATE; NORADRENALIN; PLACEBO; PROLACTIN;

ADULT; ALERTNESS; ANGER; ARTICLE; BASAL GANGLION; BOND AND LADER SCALE; CONTINGENT NEGATIVE VARIATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FATIGUE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; MOOD; MULTIPLE CYCLE TREATMENT; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PROLACTIN BLOOD LEVEL; PSYCHOLOGICAL RATING SCALE; RESPONSE TIME; STIMULUS RESPONSE; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; VISUAL STIMULATION;

ADULT; AFFECT; BASAL GANGLIA; CONTINGENT NEGATIVE VARIATION; CROSS-OVER STUDIES; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; METHYLPHENIDATE; NOREPINEPHRINE; YOUNG ADULT;

EID: 82955237427     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2345-x     Document Type: Article

References (43)

1. G Amabile F Fattapposta G Pozzessere, et al. 1986 Parkinson disease: electrophysiological (CNV) analysis related to pharmacological treatment Electroencephalogr Clin Neurophysiol 64 6 521 524 2430775 10.1016/0013-4694(86) 90189-6 1:STN:280:DyaL2s%2FltlGjtA%3D%3D (Pubitemid 17181934)
2. AF Arnsten AG Dudley 2005 Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder Behav Brain Funct 1 1 2 15916700 10.1186/1744-9081-1-2 (Pubitemid 44848793)
3. H Ashton MD Rawlins 1978 Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects Br J Clin Pharmacol 5 2 135 140 619947 1:CAS:528:DyaE1cXhvVeis70%3D (Pubitemid 8263491)
4. H Ashton JE Millman R Telford, et al. 1976 A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects Br J Clin Pharmacol 3 551 559 1:CAS:528:DyaE28XlslWrur8%3D
5. H Ashton VR Marsh JE Millman, et al. 1980 Biphasic dose-related responses of the CNV (contingent negative variation) to I.V. nicotine in man Br J Clin Pharmacol 10 6 579 589 7470371 1:CAS:528:DyaL3MXnvVWruw%3D%3D (Pubitemid 11243330)
6. M Bares I Rektor 2001 Basal ganglia involvement in sensory and cognitive processing. A depth electrode CNV study in human subjects Clin Neurophysiol 112 11 2022 2030 11682340 10.1016/S1388-2457(01)00671-X 1:STN:280: DC%2BD3MnnvFSmtA%3D%3D (Pubitemid 32995969)
7. M Bares I Rektor P Kanovsky, et al. 2003 Cortical and subcortical distribution of middle and long latency auditory and visual evoked potentials in a cognitive (CNV) paradigm Clin Neurophysiol 114 12 2447 2460 14652105 10.1016/S1388-2457(03)00250-5 (Pubitemid 37494942)
8. N Ben-Jonathan 1985 Dopamine: a prolactin-inhibiting hormone Endocr Rev 6 4 564 589 2866952 10.1210/edrv-6-4-564 1:CAS:528:DyaL28Xot1SltA%3D%3D
9. A Bond M Lader 1974 The use of analogue scales in rating subjective feelings Br J Med Psychol 47 211 218 10.1111/j.2044-8341.1974.tb02285.x
10. CH Brunia 1988 Movement and stimulus preceding negativity Biol Psychol 26 1-3 165 178 3061478 10.1016/0301-0511(88)90018-X 1:STN:280: DyaL1M%2FovVeitA%3D%3D (Pubitemid 19009426)
11. CH Brunia GJ van Boxtel 2001 Wait and see Int J Psychophysiol 43 1 59 75 11742685 10.1016/S0167-8760(01)00179-9 1:STN:280:DC%2BD3MnpsFSmsw%3D%3D (Pubitemid 33115237)
12. NJ Cooper H Keage D Hermens, et al. 2005 The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology J Integr Neurosci 4 1 123 144 16035144 10.1142/S0219635205000744 (Pubitemid 40645300)
13. J Fan R Kolster J Ghajar, et al. 2007 Response anticipation and response conflict: an event-related potential and functional magnetic resonance imaging study J Neurosci 27 9 2272 2282 17329424 10.1523/JNEUROSCI.3470-06.2007 1:CAS:528:DC%2BD2sXjsVyms7s%3D (Pubitemid 46340965)
14. M Hansenne W Pitchot E Pinto, et al. 2000 Serotonergic-1a activity and contingent negative variation Biol Psychol 52 3 259 265 10725568 10.1016/S0301-0511(99)00047-2 1:STN:280:DC%2BD3c7ptFGgtQ%3D%3D (Pubitemid 30139598)
15. DF Hermens NJ Cooper CR Clark, et al. 2007 An integrative approach to determine the best behavioral and biological markers of methylphenidate J Integr Neurosci 6 1 105 140 17472226 10.1142/S0219635207001441 (Pubitemid 46705930)
16. SD Iversen LL Iversen 2007 Dopamine: 50 years in perspective Trends Neurosci 30 5 188 193 17368565 10.1016/j.tins.2007.03.002 1:CAS:528: DC%2BD2sXkslentrc%3D (Pubitemid 46654233)
17. R Klorman E Bentsen 1975 Effects of warning-signal duration on the early and late components of the contingent negative variation Biol Psychol 3 4 263 275 1212484 10.1016/0301-0511(75)90025-3 1:STN:280:DyaE287hsFWmug%3D%3D
18. BS Kopell WK Wittner DT Lunde, et al. 1974 The effects of methamphetamine and secobarbital on the contingent negative variation amplitude Psychopharmacologia 34 1 55 62 4816728 10.1007/BF00421220 1:CAS:528: DyaE2cXptFeqsg%3D%3D
19. Leonard, B. E., McCartan, D., White, J., & King, D. J. (2004). Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19(3):151-180 (Pubitemid 38514828)
20. R Luthringer G Rinaudo M Toussaint, et al. 1999 Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers Neuropsychobiology 39 1 49 56 9892860 10.1159/000026560 1:CAS:528:DyaK1MXht1Wnurw%3D (Pubitemid 29037765)
21. McNair D, Lorr M, Droppleman L (1992) EdITS manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego
22. EJ Mulder WH Linssen EI de Geus 2002 Reduced sensory anticipation in migraine Psychophysiology 39 2 166 174 12212665 10.1111/1469-8986.3920166 (Pubitemid 34263253)
23. Y Nagai HD Critchley E Featherstone, et al. 2004 Brain activity relating to the contingent negative variation: an fMRI investigation Neuroimage 21 4 1232 1241 15050551 10.1016/j.neuroimage.2003.10.036 1:STN:280:DC%2BD2c7lvVGjtg%3D%3D (Pubitemid 38446554)
24. T Nagai K Takuma H Kamei, et al. 2007 Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex Learn Mem 14 3 117 125 17337702 10.1101/lm.461407 1:CAS:528:DC%2BD1cXms1Ortbo%3D (Pubitemid 46495188)
25. A Nieoullon 2002 Dopamine and the regulation of cognition and attention Prog Neurobiol 67 1 53 83 12126656 10.1016/S0301-0082(02)00011-4 1:CAS:528:DC%2BD38Xlt1OitLc%3D (Pubitemid 34786170)
26. M Oishi Y Mochizuki C Du, et al. 1995 Contingent negative variation and movement-related cortical potentials in parkinsonism Electroencephalogr Clin Neurophysiol 95 5 346 349 7489663 10.1016/0013-4694(95)00084-C 1:STN:280:DyaK28%2FotVWgsQ%3D%3D
27. P Papart M Ansseau M Timsit-Berthier 1997 Influence of diazepam on contingent negative variation Hum Psychopharmacol 12 95 98 10.1002/(SICI)1099- 1077(199703/04)12:2<95::AID-HUP841>3.0.CO;2-3 1:CAS:528:DyaK2sXjvF2nsLo%3D (Pubitemid 27224219)
28. KS Patrick AB Straughn RR Minhinnett, et al. 2007 Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 81 3 346 353 17339864 10.1038/sj.clpt.6100082 1:CAS:528:DC%2BD2sXktl2ltbg%3D (Pubitemid 46364487)
29. I Rektor P Kaiiovsky M Bares, et al. 2003 A SEEG study of ERP in motor and premotor cortices and in the basal ganglia Clin Neurophysiol 114 3 463 471 12705427 10.1016/S1388-2457(02)00388-7 1:STN:280:DC%2BD3s7os1artg%3D%3D (Pubitemid 36564824)
30. I Rektor M Bares P Kanovsky, et al. 2004 Cognitive potentials in the basal ganglia-frontocortical circuits. An intracerebral recording study Exp Brain Res 158 3 289 301 15221170 10.1007/s00221-004-1901-6 (Pubitemid 39304294)
31. B Rockstroh T Elbert W Lutzenberger, et al. 1991 Effects of the anticonvulsant benzodiazepine clonazepam on event-related brain potentials in humans Electroencephalogr Clin Neurophysiol 78 2 142 149 1704837 10.1016/0013-4694(91)90114-J 1:CAS:528:DyaK3MXkt1ajt70%3D
32. TJ Spencer J Biederman PE Ciccone, et al. 2006 PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate Am J Psychiatry 163 3 387 395 16513858 10.1176/appi.ajp.163.3.387 (Pubitemid 44469379)
33. JJ Tecce 1972 Contingent negative variation (CNV) and psychological processes in man Psychol Bull 77 2 73 108 4621420 10.1037/h0032177 1:STN:280:DyaE38%2Fot1eruw%3D%3D
34. JJ Tecce 1991 Dopamine and CNV: studies of drugs, disease and nutrition Electroencephalogr Clin Neurophysiol Suppl 42 153 164 1680669 1:STN:280:DyaK38%2FgslCjsg%3D%3D
35. JJ Tecce JO Cole 1974 Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain activity (CNV) Science 185 149 451 453 4841149 10.1126/science.185.4149.451 1:CAS:528:DyaE2MXis1Whtw%3D%3D
36. JJ Tecce JO Cole J Savignano-Bowman 1975 Chlorpromazine effects on brain activity (contingent negative variation) and reaction time in normal women Psychopharmacologia 43 3 293 295 1187962 10.1007/BF00429268 1:CAS:528: DyaE2MXlslarsLk%3D
37. GJ van Boxtel CH Brunia 1994 Motor and non-motor aspects of slow brain potentials Biol Psychol 38 1 37 51 7999929 10.1016/0301-0511(94)90048-5 (Pubitemid 24267461)
38. ND Volkow GJ Wang SJ Gatley, et al. 1996 Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects Psychopharmacology (Berl) 123 1 26 33 10.1007/BF02246277 1:CAS:528:DyaK28XjtVKhtLg%3D (Pubitemid 26040250)
39. ND Volkow GJ Wang JS Fowler, et al. 1998 Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 10 1325 1331 9766762 1:STN:280:DyaK1cvjvVWmsA%3D%3D (Pubitemid 28471187)
40. ND Volkow GJ Wang JS Fowler, et al. 1998 Differences in regional brain metabolic responses between single and repeated doses of methylphenidate Psychiatry Res 83 1 29 36 9754703 10.1016/S0925-4927(98)00025-0 1:CAS:528:DyaK1cXmtFWltb8%3D (Pubitemid 28384469)
41. ND Volkow JS Fowler GJ Wang, et al. 2002 Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies Eur Neuropsychopharmacol 12 6 557 566 12468018 10.1016/S0924-977X(02)00104-9 1:CAS:528:DC%2BD38XptFeksbw%3D (Pubitemid 35414373)
42. ND Volkow JS Fowler GJ Wang, et al. 2008 Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task PLoS ONE 3 4 e2017 18414677 10.1371/journal.pone.0002017 (Pubitemid 352003394)
43. WG Walter R Cooper VJ Aldridge, et al. 1964 Contingent negative variation: an electric sign of sensorimotor association and expectancy in the human brain Nature 203 380 384 14197376 10.1038/203380a0 1:STN:280: DyaF2M%2FgtFOntQ%3D%3D